Lloyd-Travaglini, Christine
Boston University
5 papers on CoChatORCID 0000-0002-8714-5303
Most cited papers
- Verified
Screening and Brief Intervention for Drug Use in Primary Care: The ASPIRE Randomized Clinical Trial
Saitz, R., Palfai, T. P. A., Cheng, D. M., Alford, D. P., Bernstein, J. A., Lloyd-Travaglini, C. A., Meli, S. M., Chaisson, C. E., & Samet, J. H. (2014) · JAMA
Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment
Cited by 280
- Verified
PTSD in Urban Primary Care: High Prevalence and Low Physician Recognition
Liebschutz, J., Saitz, R., Brower, V., Keane, T. M., Lloyd-Travaglini, C., Averbuch, T., & Samet, J. H. (2007) · Journal of General Internal Medicine
Posttraumatic Stress Disorder ResearchMigration, Health and Trauma
Cited by 223
- Verified
Discrepancy in Diagnosis and Treatment of Post-traumatic Stress Disorder (PTSD): Treatment for the Wrong Reason
Meltzer, E. C., Averbuch, T., Samet, J. H., Saitz, R., Jabbar, K., Lloyd-Travaglini, C., & Liebschutz, J. M. (2012) · The Journal of Behavioral Health Services & Research
Posttraumatic Stress Disorder ResearchMigration, Health and Trauma
Cited by 53
- Verified
HIV and substance use stigma, intersectional stigma and healthcare among HIV-positive PWID in Russia
Vetrova, M. V., Cheng, D. M., Bendiks, S., Gnatienko, N., Lloyd-Travaglini, C., Jiang, W., Luoma, J., Blokhina, E., Krupitsky, E., Lioznov, D., et al. (2021) · AIDS and Behavior
HIV, Drug Use, Sexual RiskHIV/AIDS Research and Interventions
Cited by 52
- Verified
Screening and brief intervention for drug use in primary care: the assessing screening plus brief intervention’s resulting efficacy to stop drug use (ASPIRE) randomized trial
Saitz, R., Palfai, T. P., Cheng, D. M., Alford, D. P., Bernstein, J. A., Lloyd-Travaglini, C. A., Meli, S. M., Chaisson, C. E., & Samet, J. H. (2013) · Addiction Science & Clinical Practice
Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment
Cited by 5
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free